Draupnir

Developer of small molecule therapeutics targeting extracellular and membrane-bound proteins

placeDenmark calendar_todayFounded 2015 groups18 employees language draupnir.bio

Registered entities

Social engagement

Social engagement: 2.3K social following, 3 posts in the last 12 months — below the industry typical range.

Investor mix

6 investors on record; lead investors include MP Healthcare Venture Management, Danmarks Eksport og Investeringsfond, Gilde Healthcare, Inkef.

Investor typeCountShare
Venture capital350%
Private equity117%
Other / undisclosed233%

Recent activity

12 Mar 2026
Event
TPD & Induced Proximity Summit
Coming soon